AGR Summary
Auxilium Pharmaceuticals, Inc.
(NASD:AUXL)
Conservative
(95)
| Industry: | Pharmaceuticals - Diversified | Period End: | Mar 31, 2010 (Fiscal 2010 Q-1) | Statement Filing: | May 7, 2010 (10-Q) |
|---|---|---|---|---|---|
| Market Cap: | USD 1,212.7mm (Mid Cap) | Last Audit: | PriceWaterhouseCoopers LLP | Rating Published: | Jun 18, 2010 |
OVERVIEW
Auxilium Pharmaceuticals, Inc.
is currently rated as having
Conservative Accounting & Governance Risk (AGR).
This places them in the 95th
percentile among all companies, indicating higher accounting and governance risk than
5% of companies.
RISK SUMMARY
The forensic risk summary highlights material risks, if any, and lists the most material red flagged metric for each risk. AGR Impact shows the relative weight of the various red flagged metrics by risk type.
| Risk | AGR Impact | Top Flagged Metric |
|---|---|---|
| Corporate Governance Events | 0.0% | |
| High Risk Events | 0.0% | |
| Revenue Recognition | 51.6% | Inventory/Cost of Goods Sold |
| Expense Recognition | 0.0% | |
| Asset-Liability Valuation | 48.4% | Asset Turnover |